Pages that link to "Q44547726"
Jump to navigation
Jump to search
The following pages link to Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial (Q44547726):
Displaying 50 items.
- Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant (Q24235578) (← links)
- Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant (Q24240129) (← links)
- Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention (Q24570124) (← links)
- Washing our hands of the congenital cytomegalovirus disease epidemic (Q24816634) (← links)
- Infections and Brain Development (Q26778598) (← links)
- Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit? (Q26824199) (← links)
- Cytomegalovirus antivirals and development of improved animal models (Q27000998) (← links)
- Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes (Q27010776) (← links)
- Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model (Q27026924) (← links)
- Murine CMV-induced hearing loss is associated with inner ear inflammation and loss of spiral ganglia neurons (Q27320589) (← links)
- Viral infections of the fetus and newborn infant (Q27488781) (← links)
- Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus (Q28552095) (← links)
- Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy (Q28950688) (← links)
- Cytomegalovirus infection in pregnancy (Q29994481) (← links)
- Pathological changes of cochlear in deaf mice at different time after mouse cytomegalovirus infection. (Q30406176) (← links)
- Antiviral Drug Resistance of Human Cytomegalovirus (Q30430427) (← links)
- Universal newborn hearing screening in 2010. (Q30473902) (← links)
- Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey (Q30606105) (← links)
- Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection (Q31048548) (← links)
- Selecting neonates with congenital cytomegalovirus infection for ganciclovir therapy (Q33247300) (← links)
- Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay (Q33331830) (← links)
- Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant (Q33378098) (← links)
- Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection. (Q33386281) (← links)
- Congenital cytomegalovirus infection in Canada: Active surveillance for cases diagnosed by paediatricians (Q33413926) (← links)
- Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection (Q33416429) (← links)
- Follow-up of infants with congenital cytomegalovirus and normal fetal imaging (Q33429331) (← links)
- Symptomatic Postnatal Cytomegalovirus Testing among Very Low-Birth-Weight Infants: Indications and Outcomes (Q33431331) (← links)
- Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment (Q33568646) (← links)
- Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system (Q33585728) (← links)
- Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer (Q33650105) (← links)
- Cytomegalovirus vaccine development (Q33702990) (← links)
- Congenital Cytomegalovirus Infection in High‐Risk Canadian Infants: Report of a Pilot Screening Study (Q33780006) (← links)
- Symptomatic Congenital Cytomegalovirus Infection in Children of Seropositive Women (Q33780561) (← links)
- Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the (Q34212799) (← links)
- Prevention of maternal cytomegalovirus infection: current status and future prospects (Q34272089) (← links)
- Viral causes of hearing loss: a review for hearing health professionals (Q34431749) (← links)
- Progress toward an elusive goal: current status of cytomegalovirus vaccines (Q34434818) (← links)
- Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection (Q34483696) (← links)
- Perinatal cytomegalovirus and varicella zoster virus infections: epidemiology, prevention, and treatment (Q34667953) (← links)
- Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model (Q34885438) (← links)
- Severe late-onset multisystem cytomegalovirus infection in a premature neonate previously treated for congenital infection (Q34985030) (← links)
- Congenital cytomegalovirus infection manifesting as neonatal persistent pulmonary hypertension: report of two cases (Q35101631) (← links)
- Congenital cytomegalovirus infection in pediatric hearing loss (Q35190208) (← links)
- Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection (Q35196400) (← links)
- Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase. (Q35270303) (← links)
- Ganciclovir penetrates into the cerebrospinal fluid of an infant with congenital cytomegalovirus infection (Q35315818) (← links)
- Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study (Q35319925) (← links)
- Valganciclovir for symptomatic congenital cytomegalovirus disease (Q35465712) (← links)
- Dried blood spots PCR assays to screen congenital cytomegalovirus infection: a meta-analysis (Q35534381) (← links)
- Congenital cytomegalovirus infection treatment (Q35582376) (← links)